Skip to main content
OpenTrials

Clinical trial condition

Microsatellite Instability

Explore clinical trials studying Microsatellite Instability. Study availability and eligibility vary by location and protocol.

30 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Microsatellite Instability trial results

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

NCT06004245

Conditions
Advanced Solid Tumors, Colonic Diseases, Colorectal Cancer, +14 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • START Los Angeles Los Angeles, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 38 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

NCT06898450

Conditions
Advanced Solid Tumors Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, +9 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • University of Louisville James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Cayuga Cancer Center Ithaca, New York, United States
View all 22 locations
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +89 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • AdventHealth Celebration Celebration, Florida, United States
View all 32 locations
View Trial Details
Recruiting

Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)

NCT05177133

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +4 more
Locations
  • Academic Medical Center, Medical Oncology Amsterdam, Netherlands
  • Amsterdam UMC, location VUmc Amsterdam, Netherlands
  • Catharina ziekenhuis Eindhoven, Netherlands
  • Medisch Centrum Leeuwarden Leeuwarden, Netherlands
View Trial Details

Related conditions